http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2091057-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate 1991-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b68d5e6a9b166daa28990343fe6912e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bb94f8d926e0945cb033239d3731622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f7661cd9c8a1f025082bb8bb1b9bc9b
publicationDate 1992-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2091057-A1
titleOfInvention Substituted 6,7-dihydroimidazo(1,5,4-ef) (1,5) benzodiazepin-6-ones, their preparation and pharmaceutical compositions
abstract Platelet activating factor antagonists of formula (I), wherein R1 is H or C1-C4 alkyl optionally substituted by a substituent selected from phenyl, halophenyl, pyridyl, (C1-C4 alkoxy) carbonyl and di-(C1-C4 alkyl) amino, or is C2-C4 alkyl substituted by hydroxyl or by one ore two C1-C4 alkoxy groups or is (CH2)nCONR7R8 where n is an integer from 1 to 4 and R7 and R8 are each independently H or C1-C4 alkyl, R2 is selected from H, OH and C1-C4 alkyl, R3 is selected from halo and C1-C4 alkyl, R4 is methyl, and p is an integer from 0 to 3 and m is an integer from 0 to 3; or a pharmaceutically acceptable salt thereof.
priorityDate 1990-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87063
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54223025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423465191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420974436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424836942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423577825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457521271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86590530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415854018
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4359525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57322921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9844243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10426
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID97045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448924711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426401222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24988880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18526942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454005604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426812071

Total number of triples: 48.